FHIT and non-small cell lung carcinoma: Based on this meta-analysis, the pooled HR for OS showed that FHIT hypermethylation was associated with worsen survival in NSCLC patients, HR = 1.73, 95% CI = 1.10–2.71, p  = 0.02.